McKesson Corporation (MCK): Sen. Markwayne Mullin disclosed a purchase $15K–$50K
Sen. Markwayne Mullin disclosed a purchase of McKesson Corporation in the $15K–$50K range.
- $15,001–$50,000
- Reported range · official band, not an exact amount
- 30 days
- Disclosure lag
- Traded
- Jan 5, 2026
- Disclosed
- Feb 4, 2026
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Dec 18, 2024CongressDisclosed purchase of MCK — reported range $1,001 - $15,000
- Oct 8, 2025CongressDisclosed sale of MCK — reported range $1,001 - $15,000
- Oct 10, 2025CongressDisclosed purchase of MCK — reported range $1,001 - $15,000
- Nov 1, 2025Federal contract · $1.4B obligatedDepartment of Veterans Affairs awarded McKesson Corporation: $1.41B obligated to date
- Nov 7, 2025InsiderOfficer sold ~$283K of MCK shares in the open market
- Nov 18, 2025CongressDisclosed purchase of MCK — reported range $1,001 - $15,000
- Dec 1, 2025Federal contract · $1.1B obligatedDepartment of Veterans Affairs awarded McKesson Corporation: $1.11B obligated to date
- Dec 2, 2025Congress · 1 personMembers of Congress: 2 purchases
- Dec 19, 2025CongressDisclosed sale of MCK — reported range $1,001 - $15,000
- Jan 1, 2026Federal contract · $1.1B obligatedDepartment of Veterans Affairs awarded McKesson Corporation: $1.09B obligated to date
- Jan 5, 2026 · this disclosureCongressDisclosed purchase of MCK — reported range $15,001 - $50,000
What came next
- Jan 5, 2026InsiderOfficer sold ~$225K of MCK shares in the open market
- Jan 5, 2026CongressDisclosed purchase of MCK — reported range $15,001 - $50,000
- Jan 16, 2026FDARecall: UDENYCA, pegfilgrastim-cbqv injection, 6 mg/0.6mL Single Dose Prefilled Syringe, Rx only, Manufactured by Accord BioPharma, Inc., 8041 Arco Corporate Drive, Su…
- Feb 1, 2026Federal contract · $1.1B obligatedDepartment of Veterans Affairs awarded McKesson Corporation: $1.06B obligated to date
- Feb 4, 2026Company filing · Form 8-K · ResultsReported its results
- Feb 4, 2026CongressDisclosed purchase of MCK — reported range $15,001 - $50,000
- Feb 6, 2026InsiderOfficer sold ~$313K of MCK shares in the open market
- Feb 10, 2026Layoff notice · 2700 North America Avenue West Seneca, NY, 14224Layoff notice filed in NY: 78 employees
- Feb 11, 2026InsiderOfficer sold ~$283K of MCK shares in the open market
- Feb 17, 2026InsiderOfficer sold ~$180K of MCK shares in the open market
- Feb 19, 2026InsiderDirector sold ~$328K of MCK shares in the open market
- Mar 1, 2026Federal contract · $1.2B obligatedDepartment of Veterans Affairs awarded McKesson Corporation: $1.18B obligated to date
- Mar 2, 2026InsiderOfficer sold ~$2.7M of MCK shares in the open market
- Mar 3, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On March 3, 2026, Britt J. Vitalone, the company’s Executive Vice President and Chief Financial Officer, gave notice of his intention to retire from that role. Mr. Vitalone’s last day as our CFO will be May 28, 2026, and he will remain an employee through July 1, 2026.”
- Mar 27, 20265% stakeThe Vanguard Group reported a passive stake (13G)
- Apr 1, 2026Company filing · Form 8-K · Material agreement, New debtSigned an important agreement, and took on new debt or obligations
- Apr 8, 2026CongressDisclosed partial sale of MCK — reported range $1,001 - $15,000
- Apr 28, 2026Company filing · Form 8-K · Material agreement, Agreement endedSigned an important agreement, and ended an important agreement (and 1 more item)
- Apr 30, 20265% stakeVanguard Capital Management reported a passive stake (13G) of 7.5%
How to read Senate eFD periodic transaction report
The STOCK Act is a 2012 US law that requires members of Congress, and some senior staff, to publicly report their stock trades, and those of their spouse and dependent children, within 45 days.
Full guide: What is the STOCK Act?
What else is on file for McKesson Corporation
For McKesson Corporation, OQRO holds 7 insider filings (SEC Form 4 or Form 144), 2 fund holdings reports (13F) and 2 federal contract awards dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its MCK page.
Other recent filings by Sen. Markwayne Mullin
- Senate eFD periodic transaction report at UnitedHealth (UNH)Mar 10, 2026
- Senate eFD periodic transaction report at AutoZone (AZO)Mar 10, 2026
- Senate eFD periodic transaction report at Intuit (INTU)Mar 10, 2026
- Senate eFD periodic transaction report at Monolithic Power Systems (MPWR)Mar 2, 2026
- Senate eFD periodic transaction report at McKesson Corporation (MCK)Mar 2, 2026
The full history of Sen. Markwayne Mullin is on the profile page.
How this filing works
Explore the data
Common questions
Which member of Congress traded McKesson Corporation (MCK) stock, and how much?
Sen. Markwayne Mullin disclosed a purchase of McKesson Corporation in the $15K–$50K range. Reported range, not an exact amount, Spouse account.
When did it happen, and when was it made public?
Traded: Jan 5, 2026. Disclosed: Feb 4, 2026. That is 30 days between the two dates.
Why is the amount a range and not an exact figure?
Members of Congress report each trade in a bracket set by law ($1,001 to $15,000, $15,001 to $50,000, and so on), never an exact amount. OQRO keeps the bracket as filed and does not estimate a figure inside it.
Where does this information come from?
From the Senate eFD periodic transaction report, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.
What else has been disclosed about McKesson Corporation recently?
For McKesson Corporation, OQRO holds 7 insider filings (SEC Form 4 or Form 144), 2 fund holdings reports (13F) and 2 federal contract awards dated in the last 90 days. They are listed on the MCK page.
Does this mean MCK stock is a buy or a sell?
No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.
Is OQRO free?
Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.
Other disclosures at McKesson Corporation
- SEC Form 13F-HRNov 16, 2026
- SEC Form 13F-HRNov 16, 2026
- SEC Form 4Nov 6, 2026
- SEC Form 144Nov 5, 2026
- SEC Form 4Nov 5, 2026
- SEC Form 144Nov 4, 2026
Everything OQRO holds on this company is on its MCK page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
